Integrin α4β7 in HIV‐1 infection: A critical review
暂无分享,去创建一个
[1] M. Proschan,et al. An open-label phase 1 clinical trial of the anti-α4β7 monoclonal antibody vedolizumab in HIV-infected individuals , 2019, Science Translational Medicine.
[2] J. Lifson,et al. Blocking α4β7 integrin binding to SIV does not improve virologic control , 2019, Science.
[3] K. Reimann,et al. Lack of therapeutic efficacy of an antibody to α4β7 in SIVmac251-infected rhesus macaques , 2019, Science.
[4] M. Proschan,et al. Evaluation of an antibody to α4β7 in the control of SIVmac239-nef-stop infection , 2019, Science.
[5] J. Mascola,et al. Delayed vaginal SHIV infection in VRC01 and anti-α4β7 treated rhesus macaques , 2019, PLoS pathogens.
[6] Kathy O. Lui,et al. Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after cART interruption in humanized mice. , 2019, AIDS.
[7] K. To,et al. Vedolizumab-mediated integrin α4β7 blockade does not control HIV-1SF162 rebound after combination antiretroviral therapy interruption in humanized mice. , 2019, AIDS.
[8] H. Ueno,et al. Anti-α4β7 therapy targets lymphoid aggregates in the gastrointestinal tract of HIV-1–infected individuals , 2018, Science Translational Medicine.
[9] M. Soares,et al. MAdCAM costimulation through Integrin-alpha(4)beta(7) promotes HIV replication , 2018 .
[10] M. Soares,et al. MAdCAM costimulation through Integrin-α4β7 promotes HIV replication , 2018, Mucosal Immunology.
[11] A. Fauci,et al. The Role of Integrin α4β7 in HIV Pathogenesis and Treatment , 2018, Current HIV/AIDS Reports.
[12] A. Fauci,et al. Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120 , 2018, Proceedings of the National Academy of Sciences.
[13] R. Kaul,et al. Integrin α4β7 expression on peripheral blood CD4+ T cells predicts HIV acquisition and disease progression outcomes , 2018, Science Translational Medicine.
[14] A. Fauci,et al. Virion incorporation of integrin α4β7 facilitates HIV-1 infection and intestinal homing , 2017, Science Immunology.
[15] Jace W. Jones,et al. Sustained virologic control in SIV+ macaques after antiretroviral and alpha(4)beta(7) antibody therapy , 2017 .
[16] Jace W. Jones,et al. Sustained virologic control in SIV+ macaques after antiretroviral and α4β7 antibody therapy , 2016, Science.
[17] R. Kaul,et al. Identification of preferential CD4+ T-cell targets for HIV infection in the cervix , 2015, Mucosal Immunology.
[18] S. Karim,et al. South African HIV-1 subtype C transmitted variants with a specific V2 motif show higher dependence on α4β7 for replication , 2015, Retrovirology.
[19] A. Gettie,et al. Retinoic Acid Imprints a Mucosal-like Phenotype on Dendritic Cells with an Increased Ability To Fuel HIV-1 Infection , 2015, The Journal of Immunology.
[20] M. Brameier,et al. Targeting α4β7 integrin reduces mucosal transmission of SIV and protects GALT from infection , 2014, Nature Medicine.
[21] Hua-Xin Liao,et al. Envelope Glycoprotein Binding to the Integrin α4β7 Is Not a General Property of Most HIV-1 Strains , 2014, Journal of Virology.
[22] M. Lederman,et al. IL-7 induces expression and activation of integrin α4β7 promoting naive T-cell homing to the intestinal mucosa. , 2012, Blood.
[23] H. Ding,et al. Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7 , 2012, PLoS pathogens.
[24] A. Fauci,et al. The Genotype of Early-Transmitting HIV gp120s Promotes α4β7 –Reactivity, Revealing α4β7 +/CD4+ T cells As Key Targets in Mucosal Transmission , 2011, PLoS pathogens.
[25] K. Reimann,et al. Blocking of α4β7 Gut-Homing Integrin during Acute Infection Leads to Decreased Plasma and Gastrointestinal Tissue Viral Loads in Simian Immunodeficiency Virus-Infected Rhesus Macaques , 2011, The Journal of Immunology.
[26] R. Kaul,et al. The integrin α4β7 forms a complex with cell-surface CD4 and defines a T-cell subset that is highly susceptible to infection by HIV-1 , 2009, Proceedings of the National Academy of Sciences.
[27] J. Lifson,et al. α4+β7hiCD4+ memory T cells harbor most Th-17 cells and are preferentially infected during acute SIV infection , 2009, Mucosal Immunology.
[28] Carole R. Baskin,et al. Critical Loss of the Balance between Th17 and T Regulatory Cell Populations in Pathogenic SIV Infection , 2009, PLoS pathogens.
[29] D. Douek,et al. Differential Th17 CD4 T-cell depletion in pathogenic and nonpathogenic lentiviral infections. , 2008, Blood.
[30] Eva Chung,et al. HIV-1 envelope protein binds to and signals through integrin α4β7, the gut mucosal homing receptor for peripheral T cells , 2008, Nature Immunology.
[31] M. Markowitz,et al. Lack of Mucosal Immune Reconstitution during Prolonged Treatment of Acute and Early HIV-1 Infection , 2006, PLoS medicine.
[32] Christine Hogan,et al. Primary HIV-1 Infection Is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract , 2004, The Journal of experimental medicine.
[33] J. Flamm,et al. Severe CD4+ T-Cell Depletion in Gut Lymphoid Tissue during Primary Human Immunodeficiency Virus Type 1 Infection and Substantial Delay in Restoration following Highly Active Antiretroviral Therapy , 2003, Journal of Virology.
[34] C. Melief,et al. Antigen-Antibody Immune Complexes Empower Dendritic Cells to Efficiently Prime Specific CD8+ CTL Responses In Vivo1 , 2002, The Journal of Immunology.
[35] Roberts Bd,et al. Host protein incorporation is conserved among diverse HIV-1 subtypes. , 1999 .
[36] M. Zeitz,et al. HIV/SIV Enteropathy , 1998, Annals of the New York Academy of Sciences.
[37] M. Tremblay,et al. The acquisition of host-encoded proteins by nascent HIV-1. , 1998, Immunology today.
[38] R P Johnson,et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. , 1998, Science.
[39] D. Ott. Cellular proteins in HIV virions , 1997, Reviews in medical virology.
[40] C. Mackay,et al. Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. , 1997, The American journal of pathology.
[41] 坪田 一男. Keystone symposia , 1996, Current Biology.
[42] E. Berg,et al. α4β7 integrin mediates lymphocyte binding to the mucosal vascular addressin MAdCAM-1 , 1993, Cell.
[43] Y. Tanaka,et al. Selective expression of integrin alpha 4 beta 7 on a subset of human CD4+ memory T cells with Hallmarks of gut-trophism. , 1993, Journal of immunology.
[44] S. Dandekar,et al. Simian immunodeficiency virus infection of the gastrointestinal tract of rhesus macaques. Functional, pathological, and morphological changes. , 1993, The American journal of pathology.
[45] A. Lackner,et al. Distribution of SIV infection in the gastrointestinal tract of rhesus macaques at early and terminal stages of AIDS. , 1993, Journal of medical primatology.
[46] R. Kaul,et al. Integrin alpha(4)beta(7) expression on peripheral blood CD4(+) T cells predicts HIV acquisition and disease progression outcomes , 2022 .
[47] Paul,et al. Targeting alpha(4)beta(7) integrin reduces mucosal transmission of simian immunodeficiency virus and protects gut-associated lymphoid tissue from infection , 2022 .